Applied Cash And Short Term Investments vs Cash Analysis
APLT Stock | USD 1.21 0.03 2.42% |
Applied Therapeutics financial indicator trend analysis is way more than just evaluating Applied Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Applied Therapeutics is a good investment. Please check the relationship between Applied Therapeutics Cash And Short Term Investments and its Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.
Cash And Short Term Investments vs Cash
Cash And Short Term Investments vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Applied Therapeutics Cash And Short Term Investments account and Cash. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Applied Therapeutics' Cash And Short Term Investments and Cash is 0.96. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Cash in the same time period over historical financial statements of Applied Therapeutics, assuming nothing else is changed. The correlation between historical values of Applied Therapeutics' Cash And Short Term Investments and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Applied Therapeutics are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Cash And Short Term Investments i.e., Applied Therapeutics' Cash And Short Term Investments and Cash go up and down completely randomly.
Correlation Coefficient | 0.96 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Applied Therapeutics balance sheet. This account contains Applied Therapeutics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Applied Therapeutics fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Cash
Cash refers to the most liquid asset of Applied Therapeutics, which is listed under current asset account on Applied Therapeutics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Applied Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Applied Therapeutics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from Applied Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Applied Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.At this time, Applied Therapeutics' Selling General Administrative is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 69.8 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 1.65 in 2024.
Applied Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Applied Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Applied Therapeutics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 48.4M | 104.5M | 89.9M | 38.4M | 54.8M | 56.5M | |
Other Current Liab | 264K | 19.8M | 16.1M | 27.9M | 67.9M | 71.3M | |
Total Current Liabilities | 14.1M | 21.2M | 26.5M | 33.4M | 71.2M | 74.7M | |
Total Stockholder Equity | 32.6M | 81.9M | 62.5M | 4.1M | (17.1M) | (16.3M) | |
Net Tangible Assets | (19.6M) | 32.6M | 81.9M | 62.5M | 71.9M | 75.5M | |
Net Debt | (16.8M) | (55.7M) | (52.6M) | (15.8M) | (49.1M) | (46.7M) | |
Retained Earnings | (66.8M) | (160.7M) | (266.3M) | (348.8M) | (468.6M) | (445.2M) | |
Accounts Payable | 8.8M | 640K | 9.5M | 4.5M | 1.7M | 1.7M | |
Cash | 18.9M | 57.5M | 53.9M | 16.7M | 49.9M | 34.4M | |
Non Current Assets Total | 2.2M | 1.9M | 1.5M | 1.1M | 447K | 424.7K | |
Other Assets | 199K | 1.9M | 200K | 1.0 | 1.15 | 1.09 | |
Cash And Short Term Investments | 38.9M | 96.8M | 80.8M | 30.6M | 49.9M | 50.1M | |
Common Stock Shares Outstanding | 12.8M | 22.0M | 25.6M | 37.8M | 84.2M | 88.5M | |
Liabilities And Stockholders Equity | 48.4M | 104.5M | 89.9M | 38.4M | 54.8M | 56.5M | |
Non Current Liabilities Total | 1.7M | 1.3M | 891K | 878K | 797K | 1.4M | |
Other Current Assets | 7.3M | 5.3M | 7.0M | 6.5M | 4.2M | 5.0M | |
Other Stockholder Equity | 51.0M | 242.8M | 329.0M | 352.8M | 451.4M | 230.2M | |
Total Liab | 15.8M | 22.6M | 27.4M | 34.3M | 72.0M | 75.6M | |
Net Invested Capital | 32.6M | 83.0M | 63.3M | 5.1M | (16.8M) | (16.0M) | |
Total Current Assets | 46.2M | 102.6M | 88.4M | 37.3M | 54.4M | 55.4M | |
Accumulated Other Comprehensive Income | (2K) | (112K) | (107K) | 51K | 45.9K | 48.2K | |
Net Working Capital | 32.1M | 81.4M | 61.9M | 3.9M | (16.8M) | (16.0M) | |
Short Term Debt | 356K | 812K | 884K | 954K | 858K | 607.2K | |
Common Stock | 1K | 2K | 3K | 5K | 8K | 8.4K | |
Capital Stock | 1K | 2K | 3K | 5K | 8K | 8.4K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.